SEC Filing Update: #PTGX Protagonist Therapeutics, Inc. : $151.42

Sector: Healthcare | YTD: 🔼+ 73.65% The SEC disclosed Today (13-AUG-2026) that FARALLON CAPITAL MANAGEMENT LLC has INCREASED #PTGX Shares by 1.33% 🟢 * Previous Holdings: 6.35M Shares * Current Holdings: 6.43M Shares * Increase+84.21K * Increased(%)+1.33% * Ownership: 9.99% * Estimated Investment Value: $12.10M https://www.thinksabio.com/reports/isr/PTGX Institutional ownership in #PTGX has been steadily rising over the past 3 quarters in Shares: Q3 2025: 70.68M Q4 2025: 70.73M Q1 2026: 78.74M The quarterly average prices of #PTGX: Q2 2025: $48.00 Q3 2025: $56.82 Q4 2025: $81.75 Q1 2026: $88.54